Our results suggest that increased Rac1 activity contributes to social memory deficits in AD and therefore inhibiting Rac1 may provide a potential therapeutic strategy for ameliorating the social behavior deficit observed in AD patients. This evidence concerns the gene RAC1 and Alzheimer disease.